← USPTO Patent Grants

GABA agonists and antagonists affect differentiation of hematopoietic stem cells and megakaryocyte progenitors

Grant US12589114B2 Kind: B2 Mar 31, 2026

Assignee

The Board of Trustees of the Leland Stanford Junior University

Inventors

Fangfang Zhu, Irving L. Weissman

Abstract

GABRR1 is shown to be expressed on subsets of hematopoietic stem cells (HSCs) and megakaryocyte progenitors (MkPs). Inhibition of GABRR1 inhibits MkP differentiation and reduction of platelet numbers in blood. Overexpression of GABRR1 or treatment with agonists significantly promotes MkP generation and growth of megakaryocytes.

CPC Classifications

A61K 35/18 A61K 35/19 C07K 14/475 C07K 14/705 C12N 2310/20 C12N 15/1138 C12N 15/907 C12N 2506/11 C12N 2740/16043

Filing Date

2020-05-11

Application No.

17610410

Claims

7